Dow Today – VC Daily: Biotechs Seek New Skill Set From -2-
NOCD, a Chicago-based provider of a treatment for obsessive compulsive-disorder, nabbed $33 million in Series B funding. Lead investor F-Prime Capital was joined by Eight Roads Ventures, Kaiser Permanente Ventures, 7wireVentures, Health Enterprise Partners and Chicago Ventures in the round.
Tact.ai, a Sunnyvale, Calif.-based provider of customer engagement software to life science organizations, added $33 million in a new round of funding from dRx Capital, M12, Salesforce Ventures, Eli Lilly & Co. and McKesson Ventures.
Intenseye, a New York- and Istanbul-based employee health and safety software platform, collected a $25 million Series A investment. Insight Partners led the round, which included participation from Point Nine and Air Street Capital.
Vodori, a Chicago-based cloud software provider for life science companies, landed $7.5 million in Series A funding led by Baird Capital. Jim Pavlik, partner with Baird Capital’s venture capital team, will join the board.
More Health News
The number of pregnant women who are vaccinated remains relatively low compared with the national average. PHOTO: HANNAH BEIER/REUTERS
U.S. pledge to vaccinate poor countries stumbles amid logistical challenges
How accurate are Covid-19 rapid home tests, and when should you use them?
AstraZeneca breast cancer drug cuts risk of death
Most of $9.2 billion in questionable Medicare payments went to 20 insurers, investigators say
Around the Web
How a potential partnership turned into a $1.9 billion buyout for Sanofi. (Endpoints News)
Eli Lilly zeroes in on clinical trial diversity. (Fierce Biotech)
Arm amputation surgery makes a ‘phantom’ hand seem real. (STAT News)
Scientists examine children’s unique immune systems as more fall victim to Covid. (Kaiser Health News)
(END) Dow Jones Newswires
September 23, 2021 10:17 ET (14:17 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.